Moving on from Cancer-Preliminary results from a group programme at the end of adjuvant treatment

被引:0
|
作者
Jenkins, K. [1 ]
Alberry, B. [1 ]
North, V [1 ]
Pestell, S. [1 ]
Daniel, J. [1 ]
North, N. [1 ]
机构
[1] Salisbury Dist Hosp, Salisbury, Wilts, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:329 / 329
页数:1
相关论文
共 50 条
  • [21] PRELIMINARY ANALYSIS OF END RESULTS FOR CANCER OF LARYNX
    TILL, JE
    BRUCE, WR
    ELWAN, A
    TILL, MJ
    NIEDERER, J
    REID, J
    HAWKINS, NV
    RIDER, WD
    LARYNGOSCOPE, 1975, 85 (02): : 259 - 275
  • [22] Clinical profile and treatment discontinuation in a tuberculosis control state programme in Brazil: preliminary results from SINAN database
    Bezerra, Simone S.
    Guerreiro, Mara
    Pessoa, Nathany
    Athayde, Maria Paula
    Auad, Rodrigo
    Gomes, Joao Jose
    Soares Sobrinho, Jose Lamartine
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 222 - 222
  • [23] Lung cancer prevention: Moving from the end to the beginning.
    Gibson, NW
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2778S - 2778S
  • [24] The evaluation of an interactive computer programme on treatment options in early stage breast cancer: Preliminary results
    Molenaar, S
    Sprangers, MAG
    Oosterveld, P
    de Haes, JC
    MEDICAL DECISION MAKING, 1998, 18 (04) : 482 - 482
  • [25] FOLFOX4 in adjuvant treatment of colon cancer: Survival results from the mosaic trial
    de Gramont, A.
    Boni, C.
    Navarro, M.
    Tabernero, J.
    Hickish, T.
    Topham, C.
    Bonetti, A.
    Clingan, P.
    Lorenzato, C.
    Andre, T.
    ANNALS OF ONCOLOGY, 2007, 18 : VII23 - VII23
  • [26] DETERMINANTS OF TREATMENT ABANDONMENT: PRELIMINARY RESULTS FROM A GLOBAL SURVEY BY THE SIOP PODC WORKING GROUP ON TREATMENT ABANDONMENT
    Friedrich, Paola
    Lam, Catherine
    Kaur, Geetinder
    Ribeiro, Raul
    Arora, Ramandeep Singh
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1126 - 1126
  • [27] Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
    Joharatnam-Hogan, Nalinie
    Cafferty, Fay
    Hubner, Richard
    Swinson, Daniel
    Sothi, Sharmila
    Gupta, Kamalnayan
    Falk, Stephen
    Patel, Kinnari
    Warner, Nicola
    Kunene, Victoria
    Rowley, Sam
    Khabra, Komel
    Underwood, Tim
    Jankowski, Janusz
    Bridgewater, John
    Crossley, Anne
    Henson, Verity
    Berkman, Lindy
    Gilbert, Duncan
    Kynaston, Howard
    Ring, Alistair
    Cameron, David
    Din, Farhat
    Graham, Janet
    Iveson, Timothy
    Adams, Richard
    Thomas, Anne
    Wilson, Richard
    Pramesh, C. S.
    Langley, Ruth
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (11): : 854 - 862
  • [28] NEO-ADJUVANT CHEMOTHERAPY FOR OPERABLE BREAST-CANCER - PRELIMINARY-RESULTS FROM A RANDOMIZED TRIAL
    MAURIAC, L
    DURAND, M
    PIGNEUX, J
    DILHUYDY, JM
    BUSSIERES, E
    AVRIL, A
    MAREE, D
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 148 - 148
  • [29] Moving from the CLEOPATRA study to real life: Preliminary results from the GONO SUPER trial
    Garrone, Ornella
    D'Onofrio, Loretta
    Blondeaux, Eva
    Bertolini, Ilaria
    Giarratano, Tommaso
    Beano, Alessandra
    Saggia, Chiara
    Cazzaniga, Marina
    LaVerde, Nicla
    Collova, Elena
    Milani, Andrea
    De Conciliis, Enrico
    Coltelli, Luigi
    Airoldi, Mario
    Del Mastro, Lucia
    Cursano, Maria Concetta
    Michelotti, Andrea
    Vandone, Anna Maria
    Guarneri, Valentina
    Donadio, Michela
    Riva, Francesca
    Nuzzo, Annamaria
    Merlano, Marco C.
    CANCER RESEARCH, 2018, 78 (04)
  • [30] BRCA mutation in Chinese population: Preliminary results from the The Hong Kong hereditary and High-Risk Breast Cancer Programme (HRBC programme)
    Kwong, A.
    Wong, C.
    Ma, E.
    Ford, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)